# A Study Investigating the Safety, Tolerability, and Pharmacokinetics of MTP-131 in Subjects With Congestive Heart Failure

> **NCT02388464** · PHASE1 · COMPLETED · sponsor: **Stealth BioTherapeutics Inc.** · enrollment: 36 (actual)

## Conditions studied

- Congestive Heart Failure

## Interventions

- **DRUG:** MTP-131
- **DRUG:** MTP-131
- **DRUG:** MTP-131
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02388464
- **Lead sponsor:** Stealth BioTherapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2015-04
- **Final completion:** 2015-06
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2015-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02388464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02388464, "A Study Investigating the Safety, Tolerability, and Pharmacokinetics of MTP-131 in Subjects With Congestive Heart Failure". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02388464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*